Assessing the novel antitrust claims in the Humira case
In this Law360 article, the authors consider perspectives relevant to antitrust claims based on the use of “patent thickets.” A timely example is provided by...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comIn this Law360 article, the authors consider perspectives relevant to antitrust claims based on the use of “patent thickets.” A timely example is provided by...
For companies across several industries, product development and commercialization are risky endeavors. Companies often employ commercial agreements with...